Welcome to Our Forums. Once you've registered and logged in, you're primed to talk football, among other topics, with the sharpest and most experienced fantasy players on the internet.
Implying a world class virologist isn't objective because he owns a few shares is naive and cynical. You think he'd risk his reputation for a few bucks?
Is Patterson a world class virologist? I know that he was the head of the Virology Dept at Stanford for 10 years. That seems like a difficult position for a university to fill when the private sector pays millions. His job at Stanford probably had a lot of administrative duties.
Just because you keep saying this doesn't make it true. Many times he's said LL isn't for everyone and IS NOT a silver bullet.
Really? Isn't Stanford one of the top rated universities in the US? I'm pretty sure they don't let any Schlepp become the head of their department because they're good at "administration duties".
A week ago, HGEN and CYDY were about even in price. As of this moment, CYDY is 110% higher than HGEN. (down 47 cents to $2.00)
I think he's lost all the "play" money he bragged about earning on that Swiss stock on HGEN and he's just trolling to bring everyone into his world. I mean, these guys come in trying to warn us all about the dangers of investing while investing in very similar risky biotech firms. Then it turns to straight out trolling and AF quoting. I mean it's obvious that they have vested interest in other things and are just trying to affirm their bets. It borderlines on sad when people just want to bad mouth something they don't even own to make themselves feel better. I'm a big guy. I sold off enough to make flat my worst case, but I do see the potential so I'm willing to take a risk.A week ago, HGEN and CYDY were about even in price. As of this moment, CYDY is 110% higher than HGEN. (down 47 cents to $2.00)
So the HGEN crowd has nothing better to do than come in here and bash CYDY.
I like HGEN, but it is a bit alarming that they didn't choose to take a look at their interim results. Did the company offer any explanation?
I've had some correspondence with Otto over email and I think he's still pretty interested. He's been enrolling patients in the trial.
This is mindblowing that $CYDY nerds (no offense to you DH) are e-mailing docs treating COVID patients and asking for updates on leronlimab. Even crazier that they apparently respond.Dwayne Hoover said:
What will be interesting to me is on the 14th, after they do their 1 for 5 split, CYDY could still be trading higher.... BWAHAHAHAHAHAHAHAHAHAHA
It would have been good to sell HGEN today and get back in after the split. The stock will go up to 11.25 and you will still have the same value, but I think it will start to go down drastically with no news. Eventhough stock amount and price is the same value, the perception to new investors thinking of purchasing a flyer on an OTC stock is that the price will be too high.
I don't think it will be at 11.25 on the open on the 14th. It closed today at 2.25, but there are 4 trading days for people to sell off, and they will.
You're probably right. Either way, it would be a good move to sell and buy back in lower.
Oh I see that as good news as they are taking steps to make sure they can uplist Oh I see that as good news as they are taking steps to make sure they can uplist
Truthfully, I hope both drugs are successful in helping to end this crap we are in. Only a little gloating.
Yes. It tells me they aren't confident in having a drug approved any time soon. If a drug gets approved for any use, they are over $4 easy.
I thankfully don't own any HGEN, but I would guess they know this and the only reason they're doing it is for the Nasdaq uplist and they're hoping that will be more fruitful in the long-term than the reverse split will be damaging in the short term. Not uncommon for reverse splits heading into uplisting.
